CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia

Anna Ruiz, Susana Puig, Josep Malvehy, Conxi Lázaro, Michael Lynch, Anna M. Gimenez-Arnau, Lluis Puig, Julian Sánchez-Conejo, Xavier P. Estivill, Teresa Castel

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

The CDKN2A gene has been implicated in cutaneous malignant melanoma (CMM) in about 40% of families with linkage to chromosome 9p21, while a small proportion of families have mutations in the CDK4 gene. In order to estimate the importance of these genes in the predisposition to CMM in Spanish families and patients we have analysed, by SSCA, a total of 56 subjects belonging to 34 CMM families, and nine patients with multiple CMM and other neoplasia. We have detected germline CDKN2A mutations in six out of the 34 families (17%). A frameshift mutation (358delG) and four missense mutations (G59V, G101W (two cases), D84Y, and R87W) were identified. Five CMM patients from different families (14%) carried the A148T variant, which is known not to affect p16 activity. No mutations were detected in the patients with multiple CMM or other neoplasms. We have not found mutations either in exon 1β of the CDKN2A gene or in exon 2A of CDK4. Linkage analysis of the 9p21 region showed exclusion for one of the families for CMM and for four families for CMM/dysplastic naevi. This study indicates a small role for CDKN2A in Spanish CMM families and suggests that other genes are also responsible for CMM predisposition.

Original languageEnglish
Pages (from-to)490-493
Number of pages4
JournalJournal of Medical Genetics
Volume36
Issue number6
Publication statusPublished - 1999
Externally publishedYes

Fingerprint

Melanoma
Mutation
Neoplasms
p16 Genes
Exons
Cutaneous Malignant Melanoma
Dysplastic Nevus Syndrome
Genes
Frameshift Mutation
Germ-Line Mutation
Missense Mutation
Chromosomes

Keywords

  • CDK4
  • CDKN2A
  • Cutaneous malignant melanoma
  • p16

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Ruiz, A., Puig, S., Malvehy, J., Lázaro, C., Lynch, M., Gimenez-Arnau, A. M., ... Castel, T. (1999). CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia. Journal of Medical Genetics, 36(6), 490-493.

CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia. / Ruiz, Anna; Puig, Susana; Malvehy, Josep; Lázaro, Conxi; Lynch, Michael; Gimenez-Arnau, Anna M.; Puig, Lluis; Sánchez-Conejo, Julian; Estivill, Xavier P.; Castel, Teresa.

In: Journal of Medical Genetics, Vol. 36, No. 6, 1999, p. 490-493.

Research output: Contribution to journalArticle

Ruiz, A, Puig, S, Malvehy, J, Lázaro, C, Lynch, M, Gimenez-Arnau, AM, Puig, L, Sánchez-Conejo, J, Estivill, XP & Castel, T 1999, 'CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia', Journal of Medical Genetics, vol. 36, no. 6, pp. 490-493.
Ruiz, Anna ; Puig, Susana ; Malvehy, Josep ; Lázaro, Conxi ; Lynch, Michael ; Gimenez-Arnau, Anna M. ; Puig, Lluis ; Sánchez-Conejo, Julian ; Estivill, Xavier P. ; Castel, Teresa. / CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia. In: Journal of Medical Genetics. 1999 ; Vol. 36, No. 6. pp. 490-493.
@article{cf238b6a1f064c64a2cd1084e19c9a60,
title = "CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia",
abstract = "The CDKN2A gene has been implicated in cutaneous malignant melanoma (CMM) in about 40{\%} of families with linkage to chromosome 9p21, while a small proportion of families have mutations in the CDK4 gene. In order to estimate the importance of these genes in the predisposition to CMM in Spanish families and patients we have analysed, by SSCA, a total of 56 subjects belonging to 34 CMM families, and nine patients with multiple CMM and other neoplasia. We have detected germline CDKN2A mutations in six out of the 34 families (17{\%}). A frameshift mutation (358delG) and four missense mutations (G59V, G101W (two cases), D84Y, and R87W) were identified. Five CMM patients from different families (14{\%}) carried the A148T variant, which is known not to affect p16 activity. No mutations were detected in the patients with multiple CMM or other neoplasms. We have not found mutations either in exon 1β of the CDKN2A gene or in exon 2A of CDK4. Linkage analysis of the 9p21 region showed exclusion for one of the families for CMM and for four families for CMM/dysplastic naevi. This study indicates a small role for CDKN2A in Spanish CMM families and suggests that other genes are also responsible for CMM predisposition.",
keywords = "CDK4, CDKN2A, Cutaneous malignant melanoma, p16",
author = "Anna Ruiz and Susana Puig and Josep Malvehy and Conxi L{\'a}zaro and Michael Lynch and Gimenez-Arnau, {Anna M.} and Lluis Puig and Julian S{\'a}nchez-Conejo and Estivill, {Xavier P.} and Teresa Castel",
year = "1999",
language = "English",
volume = "36",
pages = "490--493",
journal = "Shock",
issn = "1073-2322",
publisher = "BMJ Publishing Group",
number = "6",

}

TY - JOUR

T1 - CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia

AU - Ruiz, Anna

AU - Puig, Susana

AU - Malvehy, Josep

AU - Lázaro, Conxi

AU - Lynch, Michael

AU - Gimenez-Arnau, Anna M.

AU - Puig, Lluis

AU - Sánchez-Conejo, Julian

AU - Estivill, Xavier P.

AU - Castel, Teresa

PY - 1999

Y1 - 1999

N2 - The CDKN2A gene has been implicated in cutaneous malignant melanoma (CMM) in about 40% of families with linkage to chromosome 9p21, while a small proportion of families have mutations in the CDK4 gene. In order to estimate the importance of these genes in the predisposition to CMM in Spanish families and patients we have analysed, by SSCA, a total of 56 subjects belonging to 34 CMM families, and nine patients with multiple CMM and other neoplasia. We have detected germline CDKN2A mutations in six out of the 34 families (17%). A frameshift mutation (358delG) and four missense mutations (G59V, G101W (two cases), D84Y, and R87W) were identified. Five CMM patients from different families (14%) carried the A148T variant, which is known not to affect p16 activity. No mutations were detected in the patients with multiple CMM or other neoplasms. We have not found mutations either in exon 1β of the CDKN2A gene or in exon 2A of CDK4. Linkage analysis of the 9p21 region showed exclusion for one of the families for CMM and for four families for CMM/dysplastic naevi. This study indicates a small role for CDKN2A in Spanish CMM families and suggests that other genes are also responsible for CMM predisposition.

AB - The CDKN2A gene has been implicated in cutaneous malignant melanoma (CMM) in about 40% of families with linkage to chromosome 9p21, while a small proportion of families have mutations in the CDK4 gene. In order to estimate the importance of these genes in the predisposition to CMM in Spanish families and patients we have analysed, by SSCA, a total of 56 subjects belonging to 34 CMM families, and nine patients with multiple CMM and other neoplasia. We have detected germline CDKN2A mutations in six out of the 34 families (17%). A frameshift mutation (358delG) and four missense mutations (G59V, G101W (two cases), D84Y, and R87W) were identified. Five CMM patients from different families (14%) carried the A148T variant, which is known not to affect p16 activity. No mutations were detected in the patients with multiple CMM or other neoplasms. We have not found mutations either in exon 1β of the CDKN2A gene or in exon 2A of CDK4. Linkage analysis of the 9p21 region showed exclusion for one of the families for CMM and for four families for CMM/dysplastic naevi. This study indicates a small role for CDKN2A in Spanish CMM families and suggests that other genes are also responsible for CMM predisposition.

KW - CDK4

KW - CDKN2A

KW - Cutaneous malignant melanoma

KW - p16

UR - http://www.scopus.com/inward/record.url?scp=0033062279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033062279&partnerID=8YFLogxK

M3 - Article

VL - 36

SP - 490

EP - 493

JO - Shock

JF - Shock

SN - 1073-2322

IS - 6

ER -